A medium pharmaceutical company was launching a new oral drug in the diabetes space and wanted to understand how having specific income criteria for their commercial copay program would affect patient enrollment and the costs of program operation.
AMCP Spring 2024 Platinum Poster and Presentation.
AMCP Spring 2024 Platinum Poster.
ISPOR Spring 2024.
A biopharma company prepping to launch a biosimilar needed to know payer segments and patient age demographics.
A pharma company needed to evaluate the likelihood that drug compendia would positively rate an off-label dosage of an FDA-approved medication to support additional payer coverage.
A biopharma company needed an appropriate pricing model for a new tablet formulation of a successful existing infusion.